J. P. Eder
Impact in
- Hematology top 10%
- Erythropoietin and Anemia Treatment
- Hematopoietic Stem Cell Transplantation
- Toxicology top 10%
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 3
- HER2/EGFR in Cancer Research 2
- Pancreatic and Hepatic Oncology Research 2
-
- Cancer therapeutics and mechanisms 7
- Co-authors
- D. P. Ryan (4 shared papers)Jeffrey G. Supko (4 shared papers)MA Goldberg (2 shared papers)JH Antin (2 shared papers)Antman Kh (2 shared papers)Lidia Schapira (2 shared papers)Beverly A. Teicher (2 shared papers)Michael V. Seiden (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (2 papers)International Journal of Oncology (1 paper)Journal of Biological Chemistry (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesIsraelJapan
In The Last Decade
J. P. Eder
21 papers receiving 401 citations
Peers
Comparison fields: 5 of 58
- Hematology 102
- Toxicology 20
- Cancer Research 64
- Oncology 107
- Genetics 42
Countries citing papers authored by J. P. Eder
This map shows the geographic impact of J. P. Eder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Eder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Eder more than expected).
Fields of papers citing papers by J. P. Eder
This network shows the impact of papers produced by J. P. Eder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Eder. The network helps show where J. P. Eder may publish in the future.
Co-authors
The 25 scholars most cited alongside J. P. Eder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. | 2001 | 103 |
| 2 | 1990 | 73 | |
| 3 | Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo. | 1989 | 61 |
| 4 | 2006 | 44 | |
| 5 | Phase I trial of escalating pentoxifylline dose with constant dose thiotepa. | 1990 | 23 |
| 6 | 1995 | 21 | |
| 7 | 2005 | 21 | |
| 8 | 1989 | 14 | |
| 9 | Glioblastoma multiforme is not a uniform disease! | 1981 | 11 |
| 10 | 1990 | 10 | |
| 11 | 2008 | 7 | |
| 12 | 1991 | 6 | |
| 13 | 1997 | 4 | |
| 14 | 2006 | 4 | |
| 15 | 2010 | 3 | |
| 16 | 2000 | 3 | |
| 17 | Elevated topoisomerase ii top ii levels in alkylating agent aa resistant breast cancer | 1991 | 2 |
| 18 | 2005 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2005 | 2 |
About J. P. Eder
J. P. Eder is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 21 papers that have together received 418 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), HER2/EGFR in Cancer Research (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Erythropoietin and Anemia Treatment (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (102 citations), Toxicology (20 citations), Cancer Research (64 citations), Oncology (107 citations) and Genetics (42 citations). J. P. Eder has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include D. P. Ryan, Jeffrey G. Supko, MA Goldberg, JH Antin, Antman Kh, Lidia Schapira, Beverly A. Teicher, Michael V. Seiden, Steven J.M. Jones and Joanna A. Davis. Their work appears in journals such as Journal of Clinical Oncology, Blood, International Journal of Oncology, Journal of Biological Chemistry and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.